Valuation: NeoGenomics, Inc.

Market Cap 2.07B 1.88B 1.74B 1.57B 2.95B 195B 3.06B 20.87B 8.28B 104B 7.78B 7.61B 331B P/E 2026 *
-67.2x
P/E 2027 * -61.3x
Enterprise Value 2.07B 1.88B 1.74B 1.57B 2.95B 195B 3.06B 20.87B 8.28B 104B 7.78B 7.61B 331B EV / Sales 2026 *
2.56x
EV / Sales 2027 * 2.34x
Free-Float
96.13%
Yield 2026 *
-
Yield 2027 * -
1 day-3.14%
1 week-4.87%
Current month-7.83%
1 month-5.09%
3 months+0.50%
6 months+91.63%
Current year+36.22%
1 week 15.67
Extreme 15.67
17.67
1 month 15.67
Extreme 15.67
18.15
Current year 7.06
Extreme 7.065
20.15
1 year 7.06
Extreme 7.065
20.15
3 years 4.72
Extreme 4.72
21.22
5 years 4.72
Extreme 4.72
41.15
10 years 4.72
Extreme 4.72
61.57
Manager TitleAgeSince
Chief Executive Officer 65 01/04/2025
President 54 01/04/2025
Director of Finance/CFO 57 02/03/2026
Director TitleAgeSince
Chairman 64 07/10/2021
Director/Board Member 63 19/07/2017
Director/Board Member 69 15/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 A Exercice

Chairperson

42,035 0.0327%
9/1/26 A Tax

General Counsel

-2,692 0.0021%
8/21/26 A Exercice

Chairperson

67,272 0.0524%
Change 5-day change 1-year change 3-year change Capi.($)
-3.14%-4.87%+54.93%-8.35% 2.07B
-0.49%+6.56%+14.83%+30.44% 114B
-0.32%+0.82%+5.59%+110.06% 104B
-1.19%+2.71%+56.20%+512.22% 46.27B
+0.62%+2.17%+10.06%+99.55% 33.33B
-0.49%+1.07%+38.81%+78.08% 30.08B
-0.02%+1.55%+38.86%+94.05% 28.56B
-0.29%+0.95%+48.27%+389.27% 22.76B
-0.70%-1.71%-18.92%-19.23% 19.92B
+1.15%+2.99%-4.11%+34.18% 17.15B
Average -0.49%+1.30%+24.45%+132.03% 42B
Weighted average by Cap. -0.35%+2.75%+19.72%+133.87%

Financials

2026 *2027 *
Net sales 808M 732M 677M 611M 1.15B 76.2B 1.19B 8.14B 3.23B 40.71B 3.03B 2.97B 129B 887M 804M 743M 671M 1.26B 83.63B 1.31B 8.93B 3.54B 44.67B 3.33B 3.26B 142B
Net income -31.2M -28.27M -26.15M -23.59M -44.46M -2.94B -46.03M -314M -125M -1.57B -117M -115M -4.99B -34.24M -31.03M -28.7M -25.9M -48.8M -3.23B -50.52M -345M -137M -1.72B -129M -126M -5.47B
Net Debt - -
Projected Income Statement - Annual - NeoGenomics, Inc.
Logo NeoGenomics, Inc.
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing, interpretation and consultative services, molecular and NGS testing, comprehensive technical and professional services offering, clinical trials and research, validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics, Fluorescence In-Situ Hybridization (FISH), Flow cytometry, Molecular testing and others.
Employees
2,500
Date Price Change Volume
13/11/26 $16.02 -3.14% 2,217,575
12/11/26 $16.54 -1.72% 1,353,309
11/11/26 $16.83 -0.77% 957,333
10/11/26 $16.96 -3.64% 1,758,997
09/11/26 $17.60 +4.51% 1,162,902
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - NeoGenomics, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
16.02USD
Average target price
23.40USD
Spread / Average Target
+46.07%